ClinicalTrials.Veeva

Menu
R

Richmond Clinical Trials | Richmond, Canada

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Brenipatide
LY3298176
Trontinemab
PF-07328948
Obexelimab
Nitric Oxide
LY3549492
Bimagrumab
RO7126209
KarX

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

10 of 13 total trials

A Study of Brenipatide in Adult Participants With Major Depressive Disorder (RENEW-MDD-1)

This study evaluates the safety and efficacy of brenipatide when administered with standard of care (SoC) compared to placebo plus SoC in delaying th...

Enrolling
Depressive Disorder, Major
Drug: Placebo
Drug: Brenipatide

This study aims to examine the efficacy and safety of obexelimab in participants with systemic lupus erythematosus (SLE).

Enrolling
Systemic Lupus Erythematosus
Drug: Placebo
Drug: Obexelimab
Locations recently updated

The purpose of this study is to assess the efficacy and safety of trontinemab in participants with early symptomatic Alzheimer's disease (AD) (mild c...

Enrolling
Alzheimers Disease
Drug: Trontinemab
Other: Placebo

The purpose of this study is to assess the safety and efficacy of brenipatide at different dose levels compared with placebo in participants with mod...

Enrolling
Asthma
Drug: Brenipatide
Drug: Placebo

The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's Disease

Enrolling
Alzheimer's Disease
Other: Placebo
Drug: KarXT

The primary objectives of this study are to evaluate the safety and reactogenicity of mRNA-1403, and to demonstrate the efficacy of mRNA-1403 to prev...

Active, not recruiting
Acute Gastroenteritis
Norovirus Acute Gastroenteritis
Biological: mRNA-1403
Biological: Placebo
Locations recently updated

The purpose of this study is to learn about the safety and effects of the study medicine (PF-07328948) for the possible treatment of heart failure (H...

Enrolling
Heart Failure
Drug: Medium Dose PF-07328948
Drug: Placebo

The purpose of this study is to evaluate the safety, tolerability, immunogenicity, pharmacokinetics, and pharmacodynamics of multiple-ascending intra...

Active, not recruiting
Alzheimers Disease
Drug: RO7126209
Drug: Placebo

The purpose of this study is to evaluate how safe and how well a treatment works compared to placebo for people with nerve pain that begins in their...

Active, not recruiting
Distal Sensory Polyneuropathy
Neuropathic Pain
Drug: Placebo
Drug: LY3848575
Locations recently updated

This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies.

Enrolling
Alzheimers Disease
Other: No Intervention

Trial sponsors

Lilly logo
Roche logo
Bristol-Myers Squibb (BMS) logo
Moderna logo
Pfizer logo
S
Z

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems